Related Experiment Video
Updated: Aug 14, 2026

14:29
Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
Published on: October 1, 2012
Advances in immunotoxins
1Department of Medicine, Vanderbilt Medical School, Nashville, Tennessee 37232.
Summary
Immunotoxin research is expanding, with significant advances in molecular biology and clinical applications. Future work will focus on peptide toxin mechanisms and targeted toxin design for treating human diseases.
Area of Science:
- Immunotoxin research and development.
Background:
- The field of immunotoxins is experiencing significant growth, evidenced by increased attendance and abstract submissions at recent symposia.
- Key advancements in the molecular biology of toxins and their clinical applications were highlighted.
Framework:
- Focus on defining the mechanism of action for peptide toxins.
- Improvements in the design of targeted toxins for therapeutic purposes.
Implementation:
- Continued research into molecular biology of toxins.
- Development of targeted toxin therapies.
Implications:
- Potential for novel therapies targeting a wide range of human diseases.
- Enhanced understanding of peptide toxin mechanisms.
- Improved design of targeted immunotoxins for clinical use.
Related Concept Videos
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

